Spectrum Spine, with a valuation of $52.7 million, is raising funds on StartEngine. It is a pre-revenue MedTech company with advanced nanotechnology to improve surgical outcomes. Spectrum Spine is bringing an implant portfolio to the market, eliminating the need for risky bone graft products with applicability in dental, orthopedics, and spine. The targeted nanotechnology of Spectrum Spine, BioBraille, induces bone growth from surface characteristics and improves surgical outcomes, reducing pain and inflammation. James Carey Robinson founded Spectrum Spine in October 2019. The current crowdfunding campaign has a minimum target of $14,998.50 and a maximum target of $1.23 million. The campaign proceeds will be used for research and development, company employment, operations, inventory, and working capital.